Cite

HARVARD Citation

    Morabito, F. et al. (2021). Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. American journal of hematology. 96 (5), pp. E168-E171. [Online]. 
  
Back to record